# MediMind — Final Documentation Audit, Evidence Validation & Synchronization Summary

**Document ID:** `AUD-MM-2026-V2`  
**Audit Date:** November 6, 2026  
**Repository Path:** `D:\projects\MediMind`  
**Active Branch:** `feature/medimind-soa-demo`  
**Scope:** Second-Stage Academic Quality Audit, Evidence Validation, Mathematical Clarification, and Deliverable Synchronization  
**Department-Neutral Platform Scope:** MediMind Clinical AI Ecosystem (Enterprise Healthcare Platform)

---

## 1. Executive Summary & Deliverable Status

This final audit summary provides a comprehensive record of the second-stage technical verification, documentation correction, and synchronization process executed across the MediMind academic case study and companion deliverables. 

In strict adherence to academic standards:
- **No Maximum Page Count Limit:** The case study expanded naturally from an earlier 24-page draft and a 36-page revision to **43 rendered Portrait A4 pages**, preserving all technical explanations, 19 added structured evidence tables in Phases 3, 4, and 5, and full 5-step mathematical formulations.
- **Strict Evidence Authority:** All numerical claims, split sizes, and architecture configurations were verified against executable source code, Pydantic schemas, JSON training logs, and Phase 20 integration test evidence.
- **Department-Neutral Presentation:** The specific phrase *"Department of Data Science & Artificial Intelligence"* has been completely excised from the case study, the audit report, and their generator scripts, reflecting MediMind's multi-department clinical enterprise architecture.
- **Rigorous Evidentiary Categorization:** Audit findings clearly distinguish between fully verified facts, reconciled corrections, disclosed limitations, and unverified claims.

### Deliverables Inventory & Verification Status

| Deliverable File | Type / Format | Size (Bytes) | Rendered Length | Verification Status |
| :--- | :---: | :---: | :---: | :---: |
| [**`MediMind_Case_Study_Final.docx`**](file:///d:/projects/MediMind/MediMind_Case_Study_Final.docx) | Word DOCX | 557,704 | 43 Pages | **VERIFIED & SYNCHRONIZED** |
| [**`MediMind_Case_Study_Final.pdf`**](file:///d:/projects/MediMind/MediMind_Case_Study_Final.pdf) | PDF (Native COM) | 1,166,836 | 43 Pages | **100% PORTRAIT A4 VERIFIED** |
| [**`MediMind_Case_Study_Audit_Report.docx`**](file:///d:/projects/MediMind/MediMind_Case_Study_Audit_Report.docx) | Word DOCX | 48,276 | 7 Pages | **VERIFIED & SYNCHRONIZED** |
| [**`MediMind_Case_Study_Audit_Report.pdf`**](file:///d:/projects/MediMind/MediMind_Case_Study_Audit_Report.pdf) | PDF (Native COM) | 402,139 | 7 Pages | **100% PORTRAIT A4 VERIFIED** |
| [**`MediMind_Numerical_Verification_Register.xlsx`**](file:///d:/projects/MediMind/MediMind_Numerical_Verification_Register.xlsx) | Excel Workbook | 15,220 | 98 Parameters | **FORMULA-LINKED AUDIT REGISTER** |
| [**`MediMind_Final_Audit_Summary.md`**](file:///d:/projects/MediMind/MediMind_Final_Audit_Summary.md) | Markdown | — | — | **AUDIT TRAIL & EVIDENCE SUMMARY** |
| [**`MediMind_Case_Study_Final_PRE_STAGE2_BACKUP.docx`**](file:///d:/projects/MediMind/MediMind_Case_Study_Final_PRE_STAGE2_BACKUP.docx) | Word DOCX | 556,947 | 42 Pages | **STAGE 2 PRE-MODIFICATION BACKUP** |
| [**`MediMind_Case_Study_Final_PRE_STAGE2_BACKUP.pdf`**](file:///d:/projects/MediMind/MediMind_Case_Study_Final_PRE_STAGE2_BACKUP.pdf) | PDF (Native COM) | 1,162,871 | 42 Pages | **STAGE 2 PRE-MODIFICATION BACKUP** |

---

## 2. Key Corrections & Modifications Made

### 2.1 Department-Neutral Cover Page Standardization
- **Primary Case Study (`MediMind_Case_Study_Final.docx`):** Page 1 contains solely the Project Title, Subtitle, Academic Year 2026–2027, and MediMind Clinical AI Platform name, followed by an explicit Word page break. The department name was completely removed.
- **Audit Report (`MediMind_Case_Study_Audit_Report.docx`):** Removed `Department of Data Science & Artificial Intelligence` from header metadata. Standardized to `Document ID: AUD-MM-2026-V2 | Academic Year 2026–2027 | MediMind Clinical AI Platform Quality Assurance`.

### 2.2 Page-Count Reconciliation & Natural Expansion
- **Investigation Finding:** Earlier drafts of the case study had 24 pages. Subsequent systematic incorporation of missing structured tables across Phase 3, Phase 4, and Phase 5, combined with standardized 5-step mathematical formulations and explicit page breaks, naturally expanded the document to **43 rendered Portrait A4 pages**.
- **Inconsistency Resolved:** The audit report previously contained a vestigial mention of "standardizing all 24 pages" in Table 3.1 alongside "42 rendered pages" in Section 7. This was reconciled: Table 3.1 now correctly states that the document expanded naturally from 24 to 43 pages, and Section 7 dynamically verifies the exact 43 pages of `MediMind_Case_Study_Final.pdf` using `pypdf`.

### 2.3 Mathematical Explanation of Asymmetric Clinical Loss
- **Theoretical Formulation Clarified:** In Section 1.7 of the case study and Section 5 of the audit report, the asymmetric loss function $L(f) = C_{\text{FN}} \cdot \text{FN} + C_{\text{FP}} \cdot \text{FP}$ is formally explained.
- **Bayes Decision Threshold Derivation:** Under statistical decision theory, assuming well-calibrated posterior probabilities $p(x) = P(Y=1 \mid X=x)$, expected loss is minimized when predicting positive if:
  $$p(x) \cdot C_{\text{FN}} \ge (1 - p(x)) \cdot C_{\text{FP}} \implies \tau^* = \frac{C_{\text{FP}}}{C_{\text{FN}} + C_{\text{FP}}}$$
- **Essential Calibration Dependency:** The audit explicitly discloses that the Bayes formula $\tau^* = C_{\text{FP}} / (C_{\text{FN}} + C_{\text{FP}})$ assumes **well-calibrated posterior probabilities**. Setting thresholds below 0.50 based purely on theoretical cost ratios without empirical validation is clinically unsafe if the model is miscalibrated or overconfident.
- **Verified Implemented Production Thresholds:** Verified from executable Python code in `ai-prediction-service/app/services/`:
  - Cardiovascular Risk (`heart_disease_service.py`): $\tau = 0.4000$ (Random Forest)
  - Diabetes Risk (`diabetes_service.py`): $\tau = 0.2500$ (MLP Classifier)
  - Fracture Detection Baseline (`fracture_service.py`): $\tau = 0.1800$ (MURA-Pretrained ResNet-18)
  - Fracture Research Candidate (Exp 8A `DualViewROIResNet18`): $\tau = 0.0100$ (Dual-view fused probability)
  - Upstream Radiographic Spatial Localization: $\tau_{\text{det}} = 0.1700$ (YOLOv8n bounding-box proposal filter)

### 2.4 Evidence Mapping Matrix (Table 2.1 in Audit Report)
- Added an authoritative four-column Evidence Mapping Matrix connecting every major audit claim to its exact supporting artifact, verification method, and audit result.

### 2.5 Numerical Verification Register Enhanced
- Updated `MediMind_Numerical_Verification_Register.xlsx` to include a second worksheet (`Audit Summary & Reconciliation`) featuring dynamic Excel formulas (`COUNTIF`, `SUM`, percentage calculations) providing an automated statistical breakdown of the 98 audited parameters.

---

## 3. Discrepancies Discovered & Ground-Truth Reconciliations

The audit resolved 11 critical numerical discrepancies between older draft text and verified repository source artifacts:

| Item # | Focus Area / Metric | Pre-Audit Draft Claim | Verified Ground Truth in Repository | Primary Source Artifact File | Resolution & Action Taken |
| :---: | :--- | :--- | :--- | :--- | :--- |
| **1** | **Diabetes Imputation Median (Insulin)** | 125.0 $\mu\text{U/mL}$ | **126.0 $\mu\text{U/mL}$** | `ai-prediction-service/artifacts/diabetes/training_report.json` | Corrected. Full-cohort median was 125.0, but train-only median ($N=537$) is strictly 126.0 to eliminate leakage. |
| **2** | **Diabetes Imputation Median (BMI)** | 32.3 $\text{kg/m}^2$ | **32.4 $\text{kg/m}^2$** | `ai-prediction-service/artifacts/diabetes/training_report.json` | Corrected. Full-cohort median was 32.3, but train-only median ($N=537$) is strictly 32.4. |
| **3** | **Cardiovascular RF Test Precision** | 67.43% | **69.37%** | `ai-prediction-service/artifacts/heart_disease/training_report.json` | Corrected. Test confusion matrix: $\text{TP}=3,967$, $\text{FP}=1,752 \implies 3,967 / (3,967 + 1,752) = 69.37\%$. |
| **4** | **Fracture Baseline ResNet-18 Precision** | 35.40% | **35.89%** | `ai-prediction-service/artifacts/fracture/training_report.json` | Corrected. Test confusion matrix: $\text{TP}=103$, $\text{FP}=184 \implies 103 / (103 + 184) = 35.89\%$. |
| **5** | **Fracture Baseline ResNet-18 NPV** | 98.66% | **98.77%** | `ai-prediction-service/artifacts/fracture/training_report.json` | Corrected. Test confusion matrix: $\text{TN}=322$, $\text{FN}=4 \implies 322 / (322 + 4) = 98.77\%$. |
| **6** | **GRAZPEDWRI-DX Paired Studies (Exp 8A)** | 2,318 paired studies | **2,318 paired studies (4,636 radiographs)** | `EXPERIMENT_8A_FREEZE_MANIFEST.json` | Disambiguated total archive studies (3,388) from paired multi-view studies (2,318: 1,620 train / 348 val / 350 test). |
| **7** | **Exp 8A Multi-View State A (Dual Detected)** | 198 studies | **207 studies (100.0% sensitivity)** | `EXPERIMENT_8A_FREEZE_MANIFEST.json` | Corrected from older draft text to exact freeze manifest state counts. |
| **8** | **Exp 8A Multi-View State B (AP Only Detected)** | 20 studies | **6 studies (100.0% sensitivity)** | `EXPERIMENT_8A_FREEZE_MANIFEST.json` | Corrected from older draft text to exact freeze manifest state counts. |
| **9** | **Shenzhen Distal Subgroup Studies** | 767 studies | **677 studies (632 TP / 93.35% sensitivity)** | `experiment8a_pediurf_results.json` | Corrected from older draft text. Denominator verified as 677 ($64.29\%$). |
| **10** | **Shenzhen Midshaft Subgroup Studies** | 203 studies | **265 studies (259 TP / 97.74% sensitivity)** | `experiment8a_pediurf_results.json` | Corrected from older draft text. Denominator verified as 265 ($25.17\%$). |
| **11** | **Shenzhen Proximal Subgroup Studies** | 83 studies | **111 studies (105 TP / 94.59% sensitivity)** | `experiment8a_pediurf_results.json` | Corrected from older draft text. Denominator verified as 111 ($10.54\%$). |

*Verification Check:* $677 + 265 + 111 = 1,053$ total studies; $632 + 259 + 105 = 996$ true positives ($94.59\%$ overall sensitivity). Arithmetic sums match perfectly.

---

## 4. Verification Methods & Tests Performed

1. **PDF Geometry & Layout Verification (`pypdf`):**
   - Verified that all 43 pages of `MediMind_Case_Study_Final.pdf` and all 7 pages of `MediMind_Case_Study_Audit_Report.pdf` measure exactly $595.3 \times 841.9\text{ pt}$ ($210 \times 297\text{ mm}$), confirming 100.0% Portrait A4 compliance with zero landscape or clipped pages.
   - Verified that every major Phase (1–7), Section (8–14), and Appendix starts on a clean, dedicated page break.
2. **Text & Content Consistency Audit (`docx` & `pypdf`):**
   - Verified that all key terms, table titles (Tables 3.1–3.6, 4.1–4.7, 5.1–5.6), and reconciled numbers exist identically in both the DOCX source and the PDF export.
   - Programmatically confirmed 0 occurrences of draft placeholders (`[DATA NEEDED]`, `[TODO]`, `[TBD]`).
3. **Excel Register Formula Validation (`openpyxl`):**
   - Inspected `MediMind_Numerical_Verification_Register.xlsx` to verify live Excel formulas (`COUNTIF`, `SUM`, percentage formulas) across both sheets, confirming 98 total parameters:
     - 84 Verified & Accurate (85.7%)
     - 11 Corrected & Reconciled (11.2%)
     - 2 Methodological Limitations Disclosed (2.0%)
     - 1 Documented Caveat (1.0%)
4. **Phase 20 SOA Integration Test Verification:**
   - Audited `Documents/MediMind_Phase20_Test_Evidence.md` to confirm the exact composition of the 128 verified checks:
     - 69 Pytest automated tests (`ai-prediction-service/tests/`)
     - 34 Complete system validation tests (`test_phase20_complete_system_validation.mjs`)
     - 5 Review queue & authorization tests (`test_phase19_review_queue_and_authorization.mjs`)
     - 5 Intake equality & cutoff tests (`test_phase16_intake_equality_and_cutoff.mjs`)
     - 4 Clinical & AI integrity tests (`test_phase17_clinical_and_ai_integrity.mjs`)
     - 10 Service health checks (`verify_system_health.mjs`, ports 5000–5008, 5173)
     - 1 Frontend production build check (Vite v8.3.0, 373 ms build time, 2,007 modules transformed)
     - Total: $69 + 34 + 5 + 5 + 4 + 10 + 1 = 128$ checks passed (100% PASS rate).

---

## 5. Explicit Methodological Limitations & Unverified Disclosures

In accordance with strict academic integrity standards, the following items are formally disclosed as unverified or constrained by methodology:

1. **Un-Deduplicated Empirical Re-Training (Omitted to Prevent Contamination):**
   - The repository data pipeline enforces cryptographic duplicate removal prior to partitioning. Because un-deduplicated datasets were quarantined to prevent data leakage, model training on corrupted splits was intentionally omitted. Claims regarding duplicate-induced score inflation are appropriately presented as theoretical and literature-backed principles rather than empirical experiment runs.
2. **Raw Per-Model Hardware Inference Latency (Replaced with System-Level Latency):**
   - End-to-end API Gateway response latency was empirically measured at **28.2 ms warm median (p95 = 41.36 ms)** via `scripts/benchmark_results.json`. However, isolated micro-benchmarks measuring raw GPU/CPU kernel execution latency per model were not run on standardized hardware. The case study transparently discloses this caveat.
3. **Shenzhen PediURF Cohort Composition (Sensitivity Only):**
   - The Shenzhen Children's Hospital PediURF external benchmark ($N = 1,053$ studies) consists exclusively of confirmed fracture-positive pediatric trauma cases. Consequently, while external sensitivity ($94.59\%$, 996/1,053) and anatomical subgroup recall are rigorously verified, specificity, false-positive rate, and ROC-AUC cannot be mathematically computed on this cohort due to the absence of healthy control studies.
4. **Calibration Limitations (Disclosed in Manuscript):**
   - The Type-2 Diabetes MLP Classifier ($\text{ECE} = 0.1037$) and Fracture Production Baseline ResNet-18 ($\text{ECE} = 0.1021$) slightly exceed the primary clinical calibration target ($\text{ECE} < 0.100$). This limitation is explicitly acknowledged in the manuscript, justifying the clinical decision-support guardrail where raw probabilities are mapped to discrete risk badges (Low, Moderate, High) with mandatory physician-in-the-loop review.

---

## 6. Formal Conclusion

The second-stage technical audit certifies that:
1. `MediMind_Case_Study_Final.docx` and `MediMind_Case_Study_Final.pdf` (43 pages) are factually accurate, mathematically consistent, and synchronized with repository source code and manifests.
2. All 19 missing structured evidence tables across Phases 3, 4, and 5 are fully articulated with exact repository numbers.
3. The cover pages are strictly department-neutral and professional.
4. All 98 parameters in `MediMind_Numerical_Verification_Register.xlsx` are formula-validated and cross-referenced.
5. All experimental boundaries, calibration limitations, and unrun experiments are transparently disclosed without fabricated claims or unverified certifications.
